Aqueous cytokines as predictors of the recurrence of macular edema after Anti-Vascular Endothelial Growth Factor and steroid therapy in diabetic.

Aqueous cytokines as predictors of the recurrence of macular edema after Anti-Vascular Endothelial Growth Factor and steroid therapy in diabetic. - Aqueous cytokines as predictors of the recurrence of macular edema in diabetic.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021244

Enrollment

Registered

2016-03-01

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macula edema

Interventions

Local administration of Anti-Vascular Endothelial Growth Factor or steroid until improvement in macula edema

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetic macula edema Patients with pseudophakic eye Patients who agree in writing to participate in this study after enough explanation.

Exclusion criteria

Exclusion criteria: Patients with phakic eye Patients who are going to undergo other intraocular surgery

Design outcomes

Primary

Measure	Time frame
The concentration of VEGF, IP-10, MCP-1, IL-1Beta, IL-6, IL-8, IL-1 and IL-12 in the aqueous humor	—

Secondary

Measure	Time frame
Central macular thickness, Flare	—

Countries

Japan

Contacts

Public ContactMakoto Gozawa

University of Fukui. Faculty of Medical Sciences Department of Ophthalmology

makoto.gozawa@gmail.com0776618403

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026